Primary Indicators | Secondary indicators | Tertiary indicators |
Corporate responsibility governance | CSR governance responsibilities | Department in charge; responsibility report; website disclosure; compliance management system; Anti-corruption and anti-corruption system and training |
Labor practice | Employment | Employee income; employee communication |
Occupational health and safety | Occupational health and safety training; medical examination and health file coverage | |
Employee development and care | Career development training; career pathways; benefits; annuities | |
Responsibility for ensuring drug supply | Drug accessibility responsibility | Business geographic breadth; business geographic depth; drug variety diversity; third-party pharmaceutical logistics distribution services; vaccine storage and transportation business; distribution and sales of bulk-buying of drugs; cold chain pharmaceutical products business; rare disease drugs operation; imported drugs operation; medical equipment operation; Chinese herbal medicine operation; anti-tumor drugs operation; specially managed drugs operation; drug reserve responsibility; business model innovation; national logistics base for Chinese herbal medicine; foreign trade development of Chinese medicine; participation in international drug procurement and marketing network construction; foreign investment and cooperation in the field of pharmacy circulation |
Drug supply assurance system | Comprehensive logistics (retail) service capabilities; pharmaceutical cold chain logistics system construction and operation; supply chain information support and innovation services; engaged in pharmaceutical import, storage, transportation, marketing and other different aspects of hardware and software development | |
Drug quality assurance system | Drug quality management system construction; GSP-related quality training; quality management system certification; drug recall system construction; expiration date drug warning mechanism; official warnings/penalties/notifications for the quality of the pharmaceutical products operated | |
Supplier, customer and consumer responsibility | Supplier responsibility | Regular audit mechanism for supplier social responsibility assessment and investigation; supplier opinion monitoring platform or management |
Customer and consumer responsibility | Information security management system certification; prescription drug compliance sales status; customer and consumer communication and complaint channel construction | |
Socio-economic responsibility | Economic contribution | Return on net assets; growth rate of main business income; administrative penalty |
Sustainable development | Leading or participating in drafting industry-related policies, regulations or standards; growth of market share of drug distribution; growth rate of net assets | |
Community development and public welfare responsibility | Community involvement | Prevention of drug abuse; information on pharmaceutical activities such as the promotion of rational drug use, pharmaceutical science, and expert clinics; pharmaceutical assistance programs; expired drug recycling activities; assistance for low-income patients; provision of a practice base for pharmaceutical-type activities |
Public welfare and special pharmaceutical events | Public charity activities and the number of beneficiaries; anti-special medicine event input | |
Environmental responsibility | Environment policy and management | The norms establishment for the recovery and disposal of expired and substandard drugs; the use of reusable drug turnover distribution containers |